McGoldrick Thomas J. 4
4 · Predictive Oncology Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
McGoldrick Thomas J.
Director
Transactions
- Award
Stock Option (right to buy)
2019-12-31+13,410→ 13,410 totalExercise: $2.61From: 2019-12-31Exp: 2029-12-31→ Common Stock (13,410 underlying) - Award
Stock Option (right to buy)
2019-09-30+990→ 990 totalExercise: $5.05From: 2019-09-30Exp: 2029-09-30→ Common Stock (990 underlying)
Holdings
- 7
Common Stock, $.01 par value
Footnotes (1)
- [F1]Share ownership totals (and exercise price in the case of stock options) have been adjusted to reflect a 1 for 10 reverse stock split effected by the issuer on October 29, 2019.